Dr. Anand Rohatgi grew up in Kenner, LA, a suburb of New Orleans (N’ Awlins). He went to Jesuit High School (Go Blue Jays!) and went on to Duke University (go Blue Devils!) where he obtained his B.S. in Biology in 1997 and his medical degree in 2002. He went on the University of Pennsylvania for Internal Medicine residency and then to UT Southwestern in 2005 for his cardiology fellowship.  He did a research year in epidemiology under James de Lemos, MD, and then joined the faculty as an Assistant Professor in 2008.

Dr. Rohatgi is a Preventive Cardiologist and sees patients at risk for heart disease as well as those with premature ASCVD, family history, or abnormal testing suggesting increased ASCVD risk.  He also interprets echocardiograms and rounds on inpatient CCU and consultative services.  He is currently the Director of Academic Development, supervising the scholarly, non-clinical phase of fellowship, the clinical cardiology T32 program, and advising junior faculty in academic development. Dr. Rohatgi was promoted to Associate Professor in 2015 and has been supported by funding from the NHLBI, the AHA, and industry to support his endeavors.

Outside of his professional duties, Dr. Rohatgi loves spending time with his wife, Dr. Susan Matulevicius, also a cardiologist at UT Southwestern, his two boys, two dogs, guinea pig, and bird! He loves playing tennis, running, hiking, spending time in rural East Texas, and doing RV trips! He is a die-hard Duke Blue devil fan and New Orleans Saints fan. His favorite food is any type of seafood, especially crawfish, as well as Thai and Korean food.


Medical School
Duke University School of Medicine (2002)
University of Pennsylvania Health System (2005), Internal Medicine
UT Southwestern Medical Center (2008), Cardiology

Research Interest

  • Biomarkers for Atherosclerosis and Coronary Artery Disease
  • High-density Lipoprotein
  • Inflammation and Atherosclerosis


Featured Publications LegendFeatured Publications

Stressing the Endothelium to Assess Localized Inflammatory Potential and the Risk for Atherosclerotic Cardiovascular Disease.
Rohatgi A, Circulation 2021 May 143 20 1946-1948
Cholesterol efflux capacity and its association with prevalent metabolic syndrome in a multi-ethnic population (Dallas Heart Study).
Akinmolayemi O, Saldanha S, Joshi PH, Deodhar S, Ayers CR, Neeland IJ, Rohatgi A, PLoS One 2021 16 9 e0257574
Lipoprotein(a) and Family History Predict Cardiovascular Disease Risk.
Mehta A, Virani SS, Ayers CR, Sun W, Hoogeveen RC, Rohatgi A, Berry JD, Joshi PH, Ballantyne CM, Khera A, J. Am. Coll. Cardiol. 2020 Aug 76 7 781-793
Impaired HDL Metabolism Links GlycA, A Novel Inflammatory Marker, with Incident Cardiovascular Events.
Riggs KA, Joshi PH, Khera A, Singh K, Akinmolayemi O, Ayers CR, Rohatgi A, J Clin Med 2019 Dec 8 12


Featured Books Legend Featured Books

Honors & Awards

  • Discovery Grant Awardee
    American Heart Association Institute of Precision Medicine (2015)
  • Young Investigator Award
    American Association of Cardiologists of Indian Origin (2010)
  • Council on Arteriosclerosis, Thrombosis, and Vascular Biology Travel Award for Young Investigators
  • Finalist - Cardiovascular Young Investigator?s Forum
    Northwestern University (2008)
  • Outstanding Resident Teaching Award

Professional Associations/Affiliations

  • American Society of Preventive Cardiology (2019)
  • American College of Cardiology
  • American Heart Association
  • Dallas County Medical Society
  • National Lipid Association
  • Texas Medical Association